Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to porosome reconstitution therapy for treating patients with cystic ...
PMI is pleased to announce that it has been awarded a group purchasing agreement for the Drug Reconstitution and Transfer Devices category with Premier, Inc. FENTON ...
Pharmaceutical Technology on MSN
Octapharma receives FDA approval for new Fibryga formulation in AFD
Fibryga is a human plasma-derived fibrinogen concentrate authorised for AFD in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results